Nationwide Children's Hospital
Nationwide Children's Hospital
Columbus, Ohio, United States12 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Teenthrive 2: Treatments for Improving Mood in Teens | depressive disorder | Recruiting | Not applicable | 2026-10-02 | NCT07475845 | |
| Intensive Crisis Intervention | Suicidal Ideation; Suicide; Suicide Threat; Suicide and Self-harm; Suicide, Attempted | Recruiting | Not applicable | 2026-09-21 | NCT06476886 | |
| Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab | Atrophy, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Atrophy, Spinal, Type II, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Spinal Muscular Atrophies of Childhood, central nervous system disorder, hereditary disease, inherited neurodegenerative disorder, motor neuron disorder, muscular atrophy, nervous system disorder, neurodegenerative disease, neuromuscular disease, proximal spinal muscular atrophy, spinal cord disorder, spinal muscular atrophy, spinal muscular atrophy, type III | Active, not recruiting | Phase 3 | 2026-09-01 | NCT05626855 | |
| ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND) | Respiration Disorders, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder | Active, not recruiting | Not stated | 2026-07-14 | NCT05388708 | |
| A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne muscular dystrophy, Muscular Disorders, Atrophic, X-linked disease, hereditary disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Recruiting | Phase 1 / Phase 2 | 2026-07-08 | NCT06138639 | |
| SAFETY-Parent: Online Learning Module to Support Parents of Suicidal Youth | Suicide; Suicide Threat; Suicide and Self-harm; Suicide, Attempted | Enrolling by invitation | Not applicable | 2026-03-16 | NCT06460220 | |
| COMPASSION S3 Post-Approval Study | Bites and Stings, Chemically-Induced Disorders, cardiovascular disorder, heart disorder, heart valve disorder, injury, poisoning, pulmonary valve insufficiency | Active, not recruiting | Not stated | 2026-02-03 | NCT04860765 | |
| Fontan Udenafil Exercise Longitudinal Assessment Trial - 2 | Single Ventricle Heart Disease | Recruiting | Phase 3 | 2025-10-28 | NCT05918211 | |
| The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, congenital heart disease, heart disorder, heart valve disorder, pulmonary valve insufficiency, tetralogy of fallot | Active, not recruiting | Not applicable | 2025-09-19 | NCT02979587 | |
| Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, Infections, Mycobacterium Infections, Nontuberculous, bacterial infectious disease, cystic fibrosis, gram-positive bacterial infections, hereditary disease, lung disorder, mycobacterial infectious disease, pancreas disorder, pulmonary non-tuberculous mycobacterial infection, respiratory system disorder | Enrolling by invitation | Not stated | 2025-05-21 | NCT06262282 | |
| Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, atrial septal defect, cardiovascular disorder, congenital heart disease, heart disorder, heart septal defect | Active, not recruiting | Not applicable | 2025-05-07 | NCT04591392 | |
| Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy | dilated cardiomyopathy 3B | Recruiting | Phase 1 | 2025-02-27 | NCT06224660 |